These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30683689)

  • 1. Split-Dose
    Zhao JM; Gusman M; Peacock JG; Wickley AB; Banks KP
    J Nucl Med Technol; 2019 Mar; 47(1):88-89. PubMed ID: 30683689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
    Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time US-
    Mauri G; Gennaro N; De Beni S; Ierace T; Goldberg SN; Rodari M; Solbiati LA
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):60-68. PubMed ID: 30288593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
    Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
    Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
    J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate Postablation
    Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
    J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.
    Shyn PB; Cubre AJ; Catalano PJ; Lee LK; Hyun H; Tuncali K; Seol JG; Levesque VM; Gerbaudo VH; Kapur T; Chao RT; Silverman SG
    Abdom Radiol (NY); 2021 Jul; 46(7):3437-3447. PubMed ID: 33606061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
    Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
    Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
    Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Tumor Ablation Procedure Duration andĀ Estimated Patient Radiation Dose: Comparing Positron Emission Tomography/CT and CT Guidance.
    Hu EY; Levesque VM; Bay CP; Seol JG; Shyn PB
    J Vasc Interv Radiol; 2020 Jul; 31(7):1052-1059. PubMed ID: 32534979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
    Thulkar S; Chawla M; Sharma P; Malhotra A; Kumar R
    Clin Nucl Med; 2012 May; 37(5):498-501. PubMed ID: 22475904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
    Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
    Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
    J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT.
    Barker DW; Zagoria RJ; Morton KA; Kavanagh PV; Shen P
    AJR Am J Roentgenol; 2005 Apr; 184(4):1096-102. PubMed ID: 15788579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
    Cazzato RL; Garnon J; Ramamurthy N; Tsoumakidou G; Imperiale A; Namer IJ; Bachellier P; Caudrelier J; Rao P; Koch G; Gangi A
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1315-21. PubMed ID: 27048487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
    Wang XL; Li H; Wang QS; Zhang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-Guided Thermal Ablation for Colorectal Liver Metastases.
    Vasiniotis Kamarinos N; Kaye EA; Sofocleous CT
    Tech Vasc Interv Radiol; 2020 Jun; 23(2):100672. PubMed ID: 32591188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2RĪ³(null) (NOG) mice by (18)F-FDG PET/CT.
    Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
    Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.